Elanda Pharma Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Elanda Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: Fats and Oils Refining and Blending | Coffee and Tea Manufacturing | All Other Food Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Grocery and Related Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers

Full name: Elanda Pharma Sp. z o.o.

Profile Updated: May 25, 2024

Elanda Pharma is a Polish company with over 25 years of experience in manufacturing medications, foodstuffs, and dietary supplements. They are licensed to manufacture and process group I - N narcotics, group II - P psychotropic substances, and veterinary products. The company provides services for non-sterile medical devices, repackaging and labeling medicinal products, medical devices, dietary supplements, foodstuffs, and cosmetics.

Headquarters
Ul. Sportowa 9
Rozprza; Lodzkie; Postal Code: 97-340

Contact Details: Purchase the Elanda Pharma Sp. z o.o. report to view the information.

Website: http://www.elanda.pl

Basic Information

Total Employees:

Purchase the Elanda Pharma Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Elanda Pharma Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Elanda Pharma Sp. z o.o. report to view the information.

Incorporation Date:

August 10, 2018

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Elanda Pharma Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

22.34%▲

Total operating revenue

21.79%▲

Operating profit (EBIT)

-200.89%▼

EBITDA

N/A

Net Profit (Loss) for the Period

-169.06%▼

Total assets

-3.66%▼

Total equity

N/A

Operating Profit Margin (ROS)

-17.77%▼

Net Profit Margin

-20%▼

Return on Equity (ROE)

N/A

Debt to Equity Ratio

N/A

Quick Ratio

-0.11%▼

Similar companies